Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic XXXX .

@entity1 @entity1066
Endoscopic therapy is effective in securing hemostasis for bleeding @entity1066 , but bleeding recurs in 10% to 30% of @entity1 . Prospective identification of @entity1 at increased risk for rebleeding is requisite to reducing rebleeding rates. We previously developed a three-component scoring system that identifies @entity1 at increased risk for rebleeding. In the present study, we prospectively validated our scoring system. Forty-seven @entity1 ranging in age from 23 to 95 years in whom endoscopic therapy for bleeding @entity1066 was successful were studied. @entity1 with pre-endoscopy scores greater than 5 or postendoscopy scores greater than 10 were stratified as high-risk, and @entity1 with pre-endoscopy scores of 5 or less and post-endoscopy scores of 10 or less as low-risk. Twenty-six @entity1 were categorized as high-risk and 19 as low-risk. All @entity1 were followed until discharged from the hospital. The rebleeding rate for high-risk @entity1 was 31% (8 of 26), compared with 0 for low-risk @entity1 (p < .05). We conclude that our scoring system accurately predicts @entity1 at increased risk for rebleeding after successful endoscopic therapy of bleeding @entity1066 .
